Search Tag: stem cells

2025 27 May

RHEACELL and AOP Health have formed a new strategic partnership to deliver breakthrough therapies for the "butterfly children's" disease and chronic venous wounds. This partnership aims to provide patients with high unmet medical needs access to innovative cell therapies.   RHEACELL, a German biotech company specialised in the development of...Read more

2017 07 May

Induced pluripotent stem cells (iPSCs) are derived from somatic cells obtained from human subjects. iPSCs can be used for disease modelling, drug screening, and regenerative therapy. iPSCs have the potential to revolutionise patient care as part of precision medicine tailored to the individual.   Derived from terminally differentiated cells,...Read more